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Abstract
Previous studies have indicated a protective effect of long chain n-3 PUFAs against cardiovascular disease; however, the
overall evidence remains uncertain, and there is a general lack of knowledge in the field of cardiovascular epidemiology in
women. Therefore, the objective of this study was to explore the association between fish intake and cardiovascular disease
among 7429 women from a prospective pregnancy cohort in Aarhus, Denmark, who were followed for 12–17 years.
Exposure information derived from a questionnaire sent to the women in gestation week 16, and daily fish consumption
was quantified based on assumptions of standard portion sizes and food tables. Information on admissions to hospital was
obtained from the Danish National Patient Registry and diagnoses of hypertensive, cerebrovascular and ischaemic heart
disease were used to define the outcome: cardiovascular disease. During the follow-up period 263 events of cardiovascular
disease were identified. Overall, there was no association between cardiovascular disease and fish intake, confidence
intervals for effect estimates in the different fish intake groups were wide, overlapped and for all but one they encompassed
unity. Restricting the analysis to women who had reported the same fish intake in a questionnaire in gestation week 30 did
not alter these findings. In conclusion, our data from a prospective cohort of relatively young and initially healthy women
from Aarhus linked with information from registries could not substantiate a protective effect of fish intake against
cardiovascular disease.
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Introduction
Cardiovascular diseases are a serious public health concern
worldwide. In Denmark more than 33000 persons are afflicted of
ischaemic heart disease each year [1], and it has been estimated by
the World Health Organisation that one third of all deaths are
attributable to cardiovascular diseases [2].
Based on observations in the Greenland Inuit, where the
incidence of coronary heart disease, and in particular acute
myocardial infarction, was very low [3] a beneficial cardiovascular
effect of the essential long chain n-3 PUFAs (LCn3FAs) has been
hypothesized. Since then evidence from observational prospective
studies [4–8] and randomized controlled trials [9–11] has
supported this hypothesis of a protective effect of fish consumption
and intake of, LCn3Fas that are obtained through fish consump-
tion, against cardiovascular diseases. Also, a review assessing
whether a valid association exists between dietary exposures and
coronary heart disease in relation to the Bradford Hill guidelines
reported moderate evidence for an effect of intake of fish and
LCn3FAs [12]. However, a much debated Cochrane review from
2004 concluded that it is unclear whether dietary or supplemental
LCn3FAs alter the risk of cardiovascular events on high risk or in
the general population, but that there was no evidence to advise
people to stop taking rich sources of LCn3FAs [13]. Likewise, a
recent review of the cardiovascular effects of LCn3FAs concluded
that while there is evidence of several beneficial cardiovascular
effects of LCn3FAs there are still many uncertainties in the field,
for example regarding risk of arrhytmic events [14], so the
evidence in the field is still contradictory.
Recently it has been emphasized by experts that women are
underrepresented in cardiovascular research [15] and an overview
of the literature reveals that there are few studies on effects of
LCn3FAs in women. The large birth cohorts that have emerged in
several countries in the last decade provide an opportunity for such
observational studies. One of the main purposes of these cohorts
was to investigate the significance of fetal or early exposures for
development and health of the offspring. Nevertheless, the
information collected on a wide range of maternal exposures
and characteristics, including diet, facilitates studies on aetiological
associations in the maternal population as well.
It can be argued that dietary intake during pregnancy might not
reflect the habitual diet of an individual; however, during the
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dations regarding fish were the same as for the general
populations. Furthermore, dietary patterns have previously been
shown to be relatively persistent from preconception, through
pregnancy and postpartum [16].
On this background the aim of the present study was to examine
the relationship between fish consumption and the risk of
cardiovascular disease approximately 12 years later in a Danish
pregnancy cohort of relatively young and initially healthy women.
In such a cohort a low number of cardiovascular events is expected,
and therefore a mixed outcome is used, including cardiovascular
diseases and the cardiovascular risk factor hypertension.
Methods
Ethics statement
The protocol for the study cohort was approved by the Central
Denmark Region Committees on Biomedical Research Ethics. An
informed consent form was used to obtain written consent from all
participants.
Since 1990, and nearly consecutively until today, all Danish-
speaking pregnant women attending routine antenatal care at the
Department of Obstetrics and Gynaecology, Aarhus University
Hospital, Denmark, have been invited to participate in the Aarhus
Birth Cohort (ABC). The department serves all pregnant women
in the area (high as well as low risk), and nearly all women in the
area comply with the antenatal care programme [17]. The study
base has been described in detail elsewhere [18,19]. In short,
women completed self-administered questionnaires in gestation
weeks 16 and 30 regarding a range of medical, obstetric,
demographic and behavioural factors. From September 1992 to
October 1996 information on fish intake was part of the data
collection and women who were enrolled during this period were
included in the study population (N=8729).
Exposure
In Denmark fish is eaten mainly as part of a hot meal, open
sandwich, or cold in a green or a pasta salad [20]. A previous study
based on pregnant women from Aarhus has shown frequencies by
which such meals are consumed to be strong and independent
predictors of variation in erythrocyte n-3 fatty acids, without
considering whether the meals contained fat or lean fish [20]. Four
questions regarding fish consumption were therefore posed: How
often did you eat (1) fish in a hot meal, (2) bread with fish, (3) green
salad or pasta salad with fish, and (4) fish oil as a supplement. The
women were asked to understand the term ‘fish’ as also comprising
roe, prawn, crab and mussel. Each question had six predefined
response categories: never, less than once per month, 1–3 times
per month, 1–2 times per week, 3–6 times per week, every day.
In the week 16 questionnaire, women in the ABC were
instructed to base their response on the period from when they
knew they were pregnant until completing the questionnaire. In
the week 30 questionnaire the women were asked to base their
response on the period from around gestation week 16 until
completing the week 30 questionnaire.
In the quantification of daily fish consumption we let the six
different frequency categories correspond to: 0, 0.5, 2, 6, 18 and
28 servings per 28 days, respectively. Furthermore, we assumed
that each serving of fish as a hot meal provided 144 g of fish, a fish
sandwich provided 29 g of fish and a fish salad provided 50 g of
fish. These values were mainly derived from work done by the
Danish Veterinary and Food Administration on portion sizes,
distributions of fish species in meals, and food tables for the Danish
population [19,21,22]. We defined six exposure groups based on
information from the week 16 questionnaire, with the lowest group
comprising women who reported never eating fish, and dividing
the remaining study participants into quintiles of daily fish intake.
These exposure groups were decided upon a priori to enable us to
investigate any possible effects in a null intake group, and still have
a relatively large comparison group (the highest quintile).
As a secondary exposure variable we combined the information
from the 16 and 30 week questionnaires to obtain a measure of
consistently reported fish consumption across the pregnancy
period. We disregarded information on fish eaten with salad,
since this contributed very little to the total fish intake. This
measure was based on the subgroup of women who reported
eating fish with the same frequency on both occasions.
Furthermore, women consuming fish as a hot meal and as an
open sandwich at different frequencies were excluded in order to
obtain maximum contrast between the exposure groups. This did,
along with the criteria of identical reporting in the two
questionnaires, result in a marked restriction of the study sample
(N=650). To ensure a monotonously increasing exposure intensity
across the exposure groups, women in this subsample were divided
into the following categories, where both the defining variables
increased progressively: fish consumption (hot meal and open
sandwiches) on both measurement occasions (1) zero times, (2)
more often, but less than once per month, (3) 1–3 times per month,
and (4) once or more often per week.
Outcome
We obtained information on all admissions to hospital regarding
the study participants from the Danish National Patient Registry
(NPR). The NPR contains information on all hospitalizations in
Denmark since 1977 [23]. We assessed diagnosis of cerebrovas-
cular diseases (International Classification of Diagnosis system 10
(ICD-10) codes I60-69, ICD-8 codes 430–438), ischaemic heart
diseases (ICD-10 codes I20-25, ICD-8 codes 410–414), and
hypertensive diseases (ICD-10 codes I10-15, ICD-8 codes 400–
404). We defined an event of cardiovascular disease as a woman
admitted to hospital with one of the diagnoses listed above, after
terminating the pregnancy with which she entered the study
population, and before the end of follow up, which was 1
December 2009.
In supplementary analyses we investigated the associations
between fish consumption and each of the endpoints: cerebrovas-
cular, hypertensive and ischaemic heart disease, separately.
Furthermore, we discerned between inpatient, outpatient and
emergency room contacts and we used information on all
diagnoses of cardiovascular disease prior to pregnancy.
Covariates
From the questionnaires we gathered information on covariates
used in the multivariable analyses. Based on the findings of
previous studies in the field, we identified a priori and investigated
the following variables as covariates: smoking prior to pregnancy
(no, ,10 cigarettes/day, .10 cigarettes/day), alcohol consump-
tion during pregnancy (,1, 1–2, 3+ drinks per week), parity (0, 1+)
prepregnant BMI treated as a continuous variable using restricted,
cubic splines [24], cohabitant status (single, cohabitant), secondary
education (no post secondary education, student while pregnant,
,3, 3–4, .5 y post secondary education), school (,8, 8–9, .9y
school), gestational diabetes (no, yes according to NPR) and
preeclampsia (no, yes according to NPR).
Statistical analyses
A total of 8729 women were enrolled in the ABC between
1992–1996. We excluded women who reported taking fish oil as a
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done to avoid the analytical difficulties of distinguishing between
effects of food and supplement derived nutrients as we were not
able to quantify intake of LCn3FAs from supplements. Further, a
complete case analysis strategy was applied, and thus data from
7429 women was included in our final study sample. Women who
entered our final study population were similar to those who were
excluded with respect to age at enrolment, parity, smoking, BMI
and cohabitant status.
Kaplan-Meier estimates of the survivor functions were investi-
gated to characterize the effect of exposure. We used Cox
regression models to investigate the risk of cardiovascular disease
associated with different levels of fish consumption, while taking a
number of covariates into account. Hazard ratios (HR) and 95%
confidence intervals (CIs) were assessed, using age as the
underlying time scale, and we applied delayed entry to account
for the fact, that women entered the cohort at different ages.
Participants were thus considered at risk from their age at the time
when they filled in the week 16 questionnaire, until the age at
cardiovascular disease diagnosis, death or the defined end of follow
up, whichever came first. Investigation of the cumulative residuals
did not reveal any violations to the assumption of proportional
hazards. Trend tests for hazard ratios were performed by
including the fish intake levels coded as 1, 2, 3, 4, 5, 6 and testing
the significance of this variable.
We adjusted for confounding by including the covariates
smoking, alcohol consumption, parity, BMI, cohabitant status,
education and school as explanatory variables simultaneously in
the models. All analyses were carried out using SAS statistical
software (version 9; SAS Institute, Cary, NC).
Supplementary and sensitivity analyses
Supplementary analyses were performed to test the robustness
of the findings. Using information on fish consumption from the
week 30 questionnaire, we conducted analyses corresponding to
the primary analyses. We also restricted the study population by
excluding women who suffered from preeclampsia or gestational
diabetes during the index pregnancy, as these might act as
intermediate variables. Compared to diagnoses based on inpatient
contacts, those based on emergency room and/or outpatient
contacts may be less valid. In a sensitivity analysis we therefore
excluded all events that were based on emergency room and/or
outpatient contacts. Furthermore, individual analyses were
conducted for each of the three endpoints (hypertensive, ischaemic
and cerebrovascular disease).
Results
Characteristics of the women in the study sample are given in
table 1. During the follow up period from 1992/1997 – 2009
(median follow up time 15 years), 263 events of cardiovascular
disease were identified in the study sample. Of these 154 were
events of hypertension, 58 were events of cerebrovascular and 51
events of ischaemic heart disease.
Women with a low fish intake were more likely to be young
(,30 y), nulliparous, smokers, overweight, have a low alcohol
intake, be less educated and more likely to suffer from
preeclampsia as compared to women with a high fish intake.
Among women who suffered from cardiovascular disease there
were more women who were older at recruitment, parous,
smoking, overweight, less educated and there were more
preeclampsia cases than among women who did not suffer from
cardiovascular disease during the study period (table 1).
Table 2 shows crude and adjusted HRs for cardiovascular
disease, with women in the highest fish intake group as the
reference group. For women in the 2
nd quintile of fish intake
(median intake 8 g/day) there was an increased risk of
cardiovascular disease adjusted HR 1.54 (95% CI 1.03, 2.28).
Regarding women in lower and higher fish intake groups risk
estimates were closer to one and CIs encompassed unity. Overall,
there was no association between cardiovascular disease and fish
intake, either when the latter was treated as a categorical (p=0.29)
or as a continuous variable (p=0.97).
The analysis in table 3 is based on the subgroup of women who
consistently reported the same frequency of fish intake in the week
16 and 30 questionnaires, restricting the study sample substan-
tially. No association between this exposure measure and risk of
cardiovascular disease was seen, adjusted HRs ranging from 0.98
(95% CI: 0.22, 4.34) to 1.92 (95% CI: 0.53, 7.04).
Shifting the exposure to fish intake from the week 30
questionnaire did not change these findings, and neither did: 1)
applying a different categorisation of fish intake (no fish intake/
lowest quintile/three middle quintiles (ref.)/highest quintile); 2) an
exclusion of women who had preeclampsia or gestational diabetes
during the index pregnancy; 3) exclusion of outpatient and/or
emergency room contact based events; or 4) using the three
endpoints as individual outcomes (data for supplementary analyses
not shown).
Discussion
In our study population of relatively young and initially healthy
Danish women, there was no clear evidence of an association
between fish intake measured during pregnancy and subsequent
risk of cardiovascular disease.
The biological properties of LCn3FAs and the pathophysiology
of cardiovascular disease make the idea of a protective effect of
seafood consumption against cardiovascular disease probable.
Physiological effects of intake of LCn3FAs include altered cell
membrane fluidity and receptor responses following incorporation
of LCn3FAs into cell membrane phospholipids [25,26], as well as
direct binding of LCn3FAs to cytosolic receptors that regulate
gene transcription [27] and complex interactions with ion
channels [28]. These mechanisms have varying dose-responses
and time-responses of effect [29]. Apparent discrepancies in the
results of previous studies might thus reflect the different responses
of effect depending upon the chosen outcome measure, as well as
differences in levels of habitual intake across study populations.
Furthermore, although most cardiovascular risk factors are shared
by men and women, there might be gender differences with regard
to their impact [30], and inflammation, HDL and triglyceride
levels might have a more negative influence on cardiovascular risk
in women than in men [30]. Since these risk factors are supposedly
affected by LCn3FA intake, this underlines a need for studies on
the importance of LCn3FAs in women.
Comparison with other studies
The setting of our study in a pregnancy cohort implied that
participants were generally young and healthy at enrolment.
These demographic characteristics and the composite outcome
definition in our study complicate comparisons with other studies
in the field.
Most of the randomized controlled trials that have been
conducted in this field have been secondary prevention trials
conducted in male study populations [9–11]. Several observational
prospective studies have shown fish consumption and LCn3FAs in
varying amounts to be inversely associated with fatal coronary
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association has been observed [31–33], or an association has been
seen for some, but not for other cardiovascular outcomes [34].
These inconsistencies are also reflected in the different reviews that
have been conducted in this area of research. In a review on health
effects associated with consumption of fish and the contaminants
that come along with it, the authors concluded that the health
benefits of fish intake outweigh risks emanating from methylmer-
cury, dioxins and PCBs [35]. Likewise, some reviews have
concluded that there is solid evidence of a protective effect of
LCn3FAs against cardiovascular mortality [29,36,37], while others
seem to unveil a more complex picture [13,14].
Only few studies have been carried out in female study
populations. Another recent Danish follow-up study including
middle-aged men and women showed an inverse association
between intake of fatty fish and risk of acute coronary syndrome in
men, but no association in women [38]. This finding is in
accordance with our study, but stands in contrast to the results
from a large observational prospective cohort of women, the
Nurses’ Health Study, where intake of fish and LCn3FAs was
found to be inversely associated with risk of coronary heart disease
[39] and thrombotic infarction [40].
Most previous studies have been carried out in populations that
were older compared to the ABC, and many have modelled
cardiovascular mortality rather than risk of incident events. This
might be the reason why our findings seem to stand in contrast to
many other studies in the field.
Strengths and weaknesses of the study
The major strengths of our study are its prospective design, the
close-to-complete follow up from high quality registry data and the
relatively detailed information on fish intake during pregnancy.
The fish intake questions have earlier been validated against
biomarkers in the study population (pregnant women in Aarhus).
A comparison of intake of LCn3FAs, estimated by a combined
dietary self-administered questionnaire and interview, with fatty
Table 1. Participants in the Aarhus Birth Cohort distributed by maternal characteristics, fish intake in gestation week 16 and
cardiovascular disease (CVD) (N=7429).
Overall Fish intake g/day
a CVD
a
NA l l
a 01
st 2
nd 3
rd 4
th 5
th P
b CVD No CVD P
b
Maternal age (%)
c ,0.0001 0.009
,20 y 68 1 7 2 1 0.2 0.5 0.4 0.4 0.9
20–29 y 982 13 31 20 15 11 9 8 10 13
3 0 – 3 9 y 3 1 1 0 4 2 3 44 54 44 04 33 9 3 5 4 2
40+y 3 2 6 9 4 4 2 83 34 04 94 85 2 5 4 4 4
Nulliparous (%)
c 4240 57 64 63 60 55 53 53 ,0.0001 47 57 0.001
Single/unmarried (%)
c 322 4 8 5 5 4 3 5 0.0007 5 4 0.62
Nonsmokers (%)
c 4855 65 50 60 65 69 67 69 ,0.0001 66 63 0.04
Alcohol during pregnancy (%)
c ,0.0001 0.2
,1 drink/week 5290 71 86 76 74 69 68 67 71 71
1–2 drinks/week 1596 21 13 19 20 23 24 24 19 21
.3 drinks/week 543 7 0.9 6 7 8 8 9 9 7
Pre-pregnant body mass index (%)
c ,0.0001 0.002
,1 8 . 5 4 6 5 6 868566 8 6
18.5–25 5795 78 69 74 75 81 78 82 69 78
.25 1169 16 24 20 17 14 16 12 23 15
School (%)
c ,0.0001 0.001
,8 y 7 5 2 1 0 2 81 51 26 7 7 1 1 1 0
8–9 y 2193 30 37 40 32 27 25 22 39 29
.1 0 y 4 4 8 4 6 0 3 54 55 76 76 87 1 5 0 6 1
Secondary education (%)
c ,0.0001 0.006
None 978 13 34 17 15 10 10 11 15 13
3 y 2236 30 34 39 36 27 27 20 35 30
.3–4 y 2544 34 17 28 31 38 36 40 37 34
S t u d e n t 9 4 4 1 3 1 01 01 01 31 41 7 7 1 3
.4 y 727 10 5 6 8 12 12 12 6 10
Preeclampsia (%)
c 1 2 6 2 3222210 . 0 1 9 1 ,0.0001
Gestational diabetes (%)
c 8 0.1 0.4 0 0.1 0.1 0.1 0.1 0.52 0 0.1 0.57
a% (columns) of women distributed by covariate/covariate within level of exposure or outcome.
bTwo-sided p-value from x2-test for measure of association.
c% (columns) of women within fish intake group.
doi:10.1371/journal.pone.0027330.t001
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respect to the power to explain FA-ratio variability, the questions
on fish consumption used in our study were comparable with
intake of LCn3FAs assessed by an elaborate semiquantitative
dietary method involving an interview [20]. Furthermore, we had
data on fish consumption for two separate periods of pregnancy
enabling us to focus on a restricted study sample who consistently
reported the same fish intake during 2nd and 3rd trimester, and
we were able to adjust for some important potential confounding
factors. Information on fish intake during pregnancy may be taken
as an estimate of the habitual intake of the study participants, as
dietary patterns have previously been shown to be relatively
persistent from preconception, through pregnancy and postpartum
[16,41]. The most frequently consumed fish species in Denmark
are cod, plaice, salmon herring, and mackerel, whereas species
with high mercury content, such as shark and king mackerel, are
not commonly consumed in Denmark [42]. Furthermore, during
recruitment and initial data collection for the ABC dietary
recommendations in Denmark did not include warnings regarding
intake of fatty fish due to the potential harm of dioxins or methyl-
mercury. Therefore it is less likely that women in the ABC have
changed their fish intake during pregnancy either due to worries
regarding harmful exposures, or due to considerations of beneficial
effects of LCn3FAs to the developing fetus.
However, the information on nutrition did not comprise data on
type of fish consumed, total energy intake or other dietary factors,
such as meat, fruit and vegetables, trans fatty acids and n-6
polyunsaturated fatty acids, which have also been associated with
cardiovascular disease. Since we are not able to disentangle dietary
intake of LCn3FAs from that of overall fish consumption this
might blur a potential underlying association between LCn3FAs
and cardiovascular diseases. Furthermore, we are not able to
adjust for some known dietary risk factors for cardiovascular
diseases, such as trans-fatty acids; and – as in any observational
study - we cannot exclude residual confounding or confounding by
factors not adjusted for.
In table 2 an increased risk of cardiovascular disease for women
with median fish intake of 8 g/day is observed. Either this finding
reflects an underlying increased risk of cardiovascular disease for
women who consume moderate vs high amounts of fish; or the
increased risk observed for the intermediate fish intake group is a
chance finding, or reflecting residual confounding. An increased
risk of cardiovascular disease related to moderate fish intake could
result from consumption of the fish types that are high in
environmental contaminants, and that positive effects of LCn3FAs
would exceed the negative effects of contaminants only at the very
highest fish intakes. However, this is largely speculative, and we
find it more likely that the increased risk observed for the
intermediate fish intake group is a chance finding, as indicated by
the p-value for the overall x
2-test of effects.
Our results are in line with a previous Danish study which also
included women in the study population, but both studies seem to
suffer under a low number of cases. Therefore it is unclear wether
our results are actually reflecting that there is no association
between fish intake and risk of CVD in these relatively young
Danish women, or whether the number of cases is simply too low
to be used as the basis for any biologically relevant conclusions.
All pregnant women in Aarhus in the recruitment period were
invited to participate in the ABC, but since it was not registered
who did not participate the actual participation rate is not known,
although it is estimated to be 76–95% for the different
questionnaires [43]. It is generally assumed that persons who
participate in large cohort studies are more health-conscious
compared to non-participants; a selection that might result in
biased effect estimates if the likelihood of being followed in the
cohort depends on both the exposure and the outcome, or bias
might be more subtly related to factors that influence exposure and
outcome. Provided that the confounding which may have been
introduced by the selection processes, is captured by the covariate
models we used, selection may not be problem. Further, we believe
that the same biological effects apply to the selected cohort as to
the target population to which we want to generalize our results.
Preeclampsia, gestational diabetes and cardiovascular disease
may share a common aetiology, or these pregnancy complications
may be on the causal pathway to cardiovascular disease.
Furthermore, women suffering from these conditions are often
advised by health personnel to change their diet, and their report
on fish intake during pregnancy might thus not be a valid estimate
Table 2. Hazard ratios (HRs) for risk of cardiovascular disease
according to fish intake among 7429 women in the Aarhus
Birth Cohort.
Cardiovascular disease
Intake of fish
No. of
cases Crude Adjusted
a
(mean g/day) N % HR 95%CI HR 95%CI
No fish intake (0) 235 3 5 0.99 (0.39–2.51) 0.77 (0.30–1.96)
Lowest quintile (3) 1470 20 49 1.38 (0.91–2.08) 1.12 (0.74–1.71)
Second quintile (8) 1404 19 62 1.73 (1.17–2.56) 1.53 (1.03–2.27)
Third quintile (13) 1609 22 57 1.23 (0.83–1.83) 1.19 (0.80–1.77)
Fourth quintile (18) 1280 17 48 1.32 (0.87–1.99) 1.27 (0.84–1.92)
Highest quintile (39) 1431 19 42 Ref - Ref -
p=0.13
b p=0.28
b
p=0.09
c p=0.61
c
HR, hazard ratio; CI, confidence interval.
aAdjusted for smoking, alcohol intake, parity, cohabitant status, school,
education and prepregnant body mass index.
bOver-all x2-test of effects.
cTest for trend.
doi:10.1371/journal.pone.0027330.t002
Table 3. Hazard ratios (HRs) for risk of cardiovascular disease
according to fish intake among 650 women in the Aarhus
Birth Cohort, who consistently reported the same fish intake
in 1st and 2nd trimester.
Cardiovascular disease
No. of
Cases Crude Adjusted
a
Intake of fish N % HR 95%CI HR 95%CI
Zero intake 139 21 4 1.35 (0.33–5.49) 0.95 (0.20–4.41)
,Each month 127 19 8 2.15 (0.65–7.15) 2.03 (0.55–7.53)
Each month 271 42 12 1.34 (0.43–4.16) 1.26 (0.39–4.03)
Each week 113 17 4 Ref - Ref -
p=0.60
b p=0.57
b
p=0.44
c p=0.88
c
HR, hazard ratio; CI, confidence interval.
aAdjusted for smoking, alcohol intake, parity, cohabitant status, school,
education and prepregnant body mass index.
bOver-all x2-test of effects.
cTest for trend.
doi:10.1371/journal.pone.0027330.t003
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suffered from preeclampsia and gestational diabetes during the
index pregnancy did not alter our findings.
Due to the demographic characteristics of the population we
expected rates of mortality and coronary heart disease to be low.
The validity of acute myocardial infarction in the NPR has
previously been examined and found to be good [44], but we
expected a low number of diagnoses of this disease among women
in the ABC. Given these circumstances we chose to investigate a
relatively broad range of cardiovascular diagnoses including
hypertension, which is actually a risk factor for atherosclerosis.
Subsequently, supplementary analyses were conducted where
hypertensive, cerebrovascular and ischaemic heart disease were
treated as individual outcomes, but this did not alter our
conclusions.
Emergency room and outpatient contacts have been included in
the NPR since 1995, but the validity of these diagnoses has been
found to be lower than for other hospital departments[45].
Therefore, in a supplementary analysis, we excluded all emergen-
cy room or outpatient contacts but our results remained
unchanged.
In the planning of this study estimations were performed
regarding the expected number of cases of cardiovascular disease
in the cohort and the power to detect differences in cardiovascular
disease risk between exposure groups. This was done based on age
and sex specific incidences of cardiovascular disease from ‘Heart
Statistics’ [1]. Given the exposure groups used in this study power
was calculated to be an acceptable 75% for detecting a difference
in risk estimate of 30% (corresponding to the difference observed
in a study on intake of fish/LCn3FAs and the risk of coronary
heart disease in women by Hu et al [39]). However, it is well
known that people who are socioeconomically advantaged are
more likely to participate in cohort studies such as the ABC.
Therefore the number of identified events of cardiovascular
disease in our study was even lower than expected, and a potential
association between fish consumption and cardiovascular disease
may thus have been attenuated. In a relatively young study
population such as the ABC early markers of cardiovascular
disease, including blood cholesterol, blood pressure or micro-
albuminuria, might be a better outcome measure; unfortunately,
this information was not available.
Conclusion
In conclusion, our data from a prospective cohort of women
who were followed up for 15 years through high-quality registries
could not substantiate a protective effect of fish intake against
cardiovascular disease. Since the incidence of cardiovascular
disease is low in women below 50 years further studies should be
carried out in larger study populations or with early markers of
cardiovascular disease as an outcome measure.
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